Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.41 EUR
Market Cap: 32.3m EUR

Wall Street
Price Targets

ALGEN Price Targets Summary
Genoway SA

Wall Street analysts forecast ALGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGEN is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

Lowest
Price Target
5.96 EUR
75% Upside
Average
Price Target
6.02 EUR
76% Upside
Highest
Price Target
6.2 EUR
82% Upside
Genoway SA Competitors:
Price Targets
RXRX
Recursion Pharmaceuticals Inc
30% Upside
6855
Ascentage Pharma Group International
0% Downside
IKT
Inhibikase Therapeutics Inc
316% Upside
BMRN
Biomarin Pharmaceutical Inc
73% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
11% Downside
BIIB
Biogen Inc
30% Upside
2487
Cutia Therapeutics
6% Upside
LYEL
Lyell Immunopharma Inc
94% Downside

Revenue
Forecast

Revenue Estimate
Genoway SA

For the last 8 years the compound annual growth rate for Genoway SA's revenue is 12%. The projected CAGR for the next 4 years is 13%.

12%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Genoway SA

For the last 8 years the compound annual growth rate for Genoway SA's operating income is 24%. The projected CAGR for the next 4 years is -9%.

24%
Past Growth
-9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Genoway SA

For the last 8 years the compound annual growth rate for Genoway SA's net income is 59%. The projected CAGR for the next 4 years is -11%.

59%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGEN's stock price target?
Price Target
6.02 EUR

According to Wall Street analysts, the average 1-year price target for ALGEN is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

What is Genoway SA's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Genoway SA's revenue is 12%. The projected CAGR for the next 4 years is 13%.

What is Genoway SA's Operating Income forecast?
Projected CAGR
-9%

For the last 8 years the compound annual growth rate for Genoway SA's operating income is 24%. The projected CAGR for the next 4 years is -9%.

What is Genoway SA's Net Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Genoway SA's net income is 59%. The projected CAGR for the next 4 years is -11%.

Back to Top